At SpOvum Technologies, they create solutions through their inventions to simplify the A.R.T. process.
Product- RoboICSI
Award-Winning SpOvum flagship product. During ICSI, RoboICSI assists the embryologist to improve outcomes, thereby enabling infertile couples to bear an infant. RoboICSI is a patent-pending product based on a groundbreaking modeling strategy that will help close the difference between production and consumption in the exponentially rising infertility industry. RoboICSI offers a new way of doing ICSI that decreases the efforts of the embryologist to do ICSI while making it more impartial. This also allows fertility clinics to manage more volumes of samples and move towards greater success rates.
RoboICSI Includes
- Micro-Manipulation- RoboICSI provides a modern method of grasping cells that provides many benefits over conventional immobilisation based on micro-pipette aspiration.
- Gentle Cell Management- The intelligent passive force-limiting technology of RoboICSI guarantees that the oocyte is never impaired while handling.
- Rapid and Hassle-Free Installation- The plug-and-play system of RoboICSI enables the user to quickly plug in the system, perform auto-calibration, and get started, all in about a day.
- Eliminates Subjectivity - Oocytes Handling- Performs repetitive activities and decreases fatigue with Increase embryologists' ability
- Fast Incorporation - RoboICSI is easy to master, allowing clinics to add it without complication to their workflow.
- Enables IVF Clinics to Accommodate Larger Volumes- Enables the clinics by streamlining the operation to accommodate more volumes